Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer

NCT07005557 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1244

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Adjuvant Therapy

Interventions

DRUG: Chemotherapy
DRUG: CDK4/6 Inhibitor
DRUG: Endocrine therapy

Sponsor

Fudan University